News Merck will appeal EU rejection of COVID drug Lagevrio CHMP says evidence for the drug is “not adequate” to show efficacy over standard care.
News CMS accused of discrimination over Alzheimer’s drug verdict Decision not to revisit coverage decision for amyloid drugs is slammed by patient groups.
News Sanofi gets FDA nod for long-acting haemophilia A drug Once-weekly Altuviiio could be potential $2 billion-plus blockbuster, according to analysts.
News Vivek Ramaswamy confirms bid for US presidency Biotech entrepreneur has launched his Vivek2024 campaign with an attack on the 'woke left'.
News French court overturns €444m fine for Novartis, Roche Says companies did not abuse a market position to push Lucentis over off-label Avastin in AMD.
News Adcomm backs Replimune melanoma drug, despite data concern Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
